top of page
News, Events and Updates
Search
Jun 7, 2011
Anavex Advances Second Lead Compound; Initiates Scale-Up Manufacturing of ANAVEX 1-41
May 22, 2011
ANAVEX 2-73 Advances Phase I Clinical Trial for Alzheimer’s Disease
May 16, 2011
Anavex Comments on New Alzheimer’s Disease Diagnostic Guidelines
May 12, 2011
Anavex Appoints Robert Chisholm to Board of Directors
May 10, 2011
Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders
Apr 19, 2011
Anavex First-in-Human Dosing Commenced in ANAVEX 2-73 Clinical Trial for Alzheimer's Disease
Apr 7, 2011
Anavex Appoints Dr. Christopher Shackleton as an Advisor
Apr 5, 2011
Anavex to Hold Annual Meeting on April 11, 2011
Mar 30, 2011
Anavex Screening Healthy Volunteers for Phase I, First-in-Human Clinical Study in AD
Mar 15, 2011
Anavex Management to Hold Live Investor Conference Call Today at 4:30PM ET
Mar 14, 2011
Anavex Receives Approval to Commence Phase I Clinical Trial in Alzheimer’s Disease
43
44
45
46
47
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
